Prevention

Leaf Group Appoints Kate Lowenstein as Senior Vice President, General Manager To Lead Well+Good and LIVESTRONG.com

Retrieved on: 
Thursday, June 2, 2022

As the former Global Editor-in-Chief of VICE.com, Lowenstein was responsible for overseeing VICEs editorial coverage around the world.

Key Points: 
  • As the former Global Editor-in-Chief of VICE.com, Lowenstein was responsible for overseeing VICEs editorial coverage around the world.
  • LIVESTRONG.com delivers trusted health, nutrition, and fitness information through its website and has a highly engaged social media community, The LIVESTRONG.com Challenge Group.
  • Kate will play a critical role in further propelling our leadership in these verticals, said Sean Moriarty, CEO of Leaf Group.
  • Ive long admired these brands role in bringing such vital topics to the forefront of the conversation, said Lowenstein.

The Center for Active Design Unveils New Fitwel Provider & Partner Programs to Support Rapid Adoption of Fitwel

Retrieved on: 
Thursday, June 2, 2022

NEW YORK, June 2, 2022 /PRNewswire/ -- The Center for Active Design (CfAD) today announced the launch of its two new membership programs, the Fitwel Provider and the Fitwel Partner programs. Designed to provide an opportunity for organizations to align with and support the tremendous growth of Fitwel, the new programs empower organizations to further promote health and well-being across their industries.    

Key Points: 
  • These new membership programs will support both Provider and Partner companies as they drive implementation of healthy building strategies and tenant satisfaction through their use and their client's use of Fitwel.
  • Fitwel will offer targeted support to Provider and Partner companies through exclusive marketing and recognition opportunities, dedicated training and resources for staff, and increased access to the Fitwel team.
  • The Fitwel Provider program is designed for industry-leading architecture, design, engineering, property management, and consulting firms committed to supporting their client's implementation of Fitwel.
  • The Fitwel Partner program is our trademark program for companies seeking to promote aligned products and demonstrate support for Fitwel's mission.

BodiMetrics Takes on Health Inequality in Wearable Health Tech Industry

Retrieved on: 
Thursday, May 12, 2022

LOS ANGELES, May 12, 2022 /PRNewswire/ -- BodiMetrics announced several new initiatives today that address health inequality in the wearable medical technology industry and increase multicultural communities' awareness of the implicit racial bias in commercial pulse oximeters. Research published by several organizations, including the New England Journal of Medicine, has raised concerns about dangerous inaccuracies in pulse oximeters, devices that measure blood oxygen, when used by African Americans and other patients with darker skin tones. Other recent studies have also found that smartwatches and fitness bands are less effective at tracking the heart rate of people of color.

Key Points: 
  • LOS ANGELES, May 12, 2022 /PRNewswire/ -- BodiMetrics announced several new initiatives today that address health inequality in the wearable medical technology industry and increase multicultural communities' awareness of the implicit racial bias in commercial pulse oximeters.
  • Our mission has always been to provide the very best data with our devices," said Neil Friedman, BodiMetrics co-founder and COO.
  • All BodiMetrics products are tested by independent third-party labs to clinical standards as well, where indicated, approved by the FDA.
  • The company provides financial wellness TV programs, video content, and digital wellness products for people of color and underserved communities.

Nursa™ Hosting Party to Celebrate Salt Lake Area Healthcare Workers

Retrieved on: 
Thursday, April 28, 2022

SALT LAKE CITY, April 28, 2022 /PRNewswire/ -- A free party this weekend will honor and celebrate area healthcare heroes.

Key Points: 
  • SALT LAKE CITY, April 28, 2022 /PRNewswire/ -- A free party this weekend will honor and celebrate area healthcare heroes.
  • 2 p.m. Saturday, April 30, 2022, at the Rice Terrace Pavilion in Liberty Park, 600 E 900 S in Salt Lake City.
  • One focus of the party is appreciation and wellness for healthcare workers.
  • That's why NursaTM wants to do what it can to give back to area frontline workers with a relaxing and entertaining day of fun and food.

In Alignment with the White House 'Clean Air in Buildings Challenge,' The Center for Active Design's Fitwel Viral Response Module Safeguards Building Occupant Health

Retrieved on: 
Wednesday, April 13, 2022

NEW YORK, April 13, 2022 /PRNewswire/ -- The Biden Administration's recently released National COVID-19 Preparedness Plan underscores the need to apply federal funding from the American Rescue Plan and Bipartisan Infrastructure Law to improve indoor air quality and ventilation in schools, universities and public buildings across the country, as a critical component to combat COVID-19.

Key Points: 
  • The Center for Active Design (CfAD), which operates the Fitwel healthy building certification, commends the White House's recognition of the role the built environment plays in human health.
  • The VRM is aligned with the White House's efforts to improve indoor air quality and prevent contamination of diseases, including COVID-19.
  • Fitwel is a rigorous, third-party healthy building certification system that sets the industry standard for evidence-based strategies to promote human health and well-being through the built environment.
  • For more information about the Fitwel VRM, visit www.fitwel.org/viral-response-module
    Fitwel is the world's leading certification system committed to building health for all.

U.S. FDA Approves CABENUVA (cabotegravir and rilpivirine) for Adolescents, Expanding the Indication of the First and Only Complete Long-Acting Injectable HIV Regimen

Retrieved on: 
Wednesday, March 30, 2022

TITUSVILLE, N.J., March 29, 2022 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (cabotegravir and rilpivirine) for the treatment of HIV-1 in virologically suppressed adolescents (HIV-1 RNA less than 50 copies per milliliter [c/mL]) who are 12 years of age or older, weigh at least 35 kg and are on a stable antiretroviral regimen, with no history of treatment failure, nor known or suspected resistance to either cabotegravir or rilpivirine.1,2 Co-developed as part of a collaboration with ViiV Healthcare, CABENUVA is the first and only complete long-acting HIV-1 treatment regimen, and the first to be made available for eligible adolescents, building on Janssen's ongoing commitment to fighting HIV and improving HIV treatment options for young people living with HIV. 

Key Points: 
  • The efficacy of CABENUVA in adolescents is extrapolated from adults with support from pharmacokinetic analyses showing similar drug exposure.
  • The adverse reactions reported by more than one patient (regardless of severity) were injection site pain (n=13) and insomnia (n=2).
  • In January 2021 , the FDA approved CABENUVA to be administered every month to adults living with HIV-1.
  • In February 2022 , the FDA approved an expanded label for CABENUVA to be administered every two months to adults living with HIV-1.

Global Fraud Detection and Prevention Market to Reach $46.4 Billion by 2026

Retrieved on: 
Friday, March 11, 2022

SAN FRANCISCO, March 11, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Fraud Detection and Prevention - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, March 11, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Fraud Detection and Prevention - Global Market Trajectory & Analytics" .
  • Fraud detection and prevention solutions are software applications that offer sophisticated analytical tools to detect and prevent fraud in real-time.
  • Amid the COVID-19 crisis, the global market for Fraud Detection and Prevention estimated at US$28.3 Billion in the year 2022, is projected to reach a revised size of US$46.4 Billion by 2026, growing at a CAGR of 14.8% over the analysis period.
  • The U.S. Market is Estimated at $9.5 Billion in 2022, While China is Forecast to Reach $8.4 Billion by 2026
    The Fraud Detection and Prevention market in the U.S. is estimated at US$9.5 Billion in the year 2022.

Best's Review Evaluates Mortality Trends and Possible COVID-19 Undercount

Retrieved on: 
Thursday, March 10, 2022

In the March issue of Bests Review, industry experts examine the mortality figures and their impact, including their potential effect on future underwriting practices.

Key Points: 
  • In the March issue of Bests Review, industry experts examine the mortality figures and their impact, including their potential effect on future underwriting practices.
  • Read more in Mortality Trends Raise Underwriting Questions for Life Insurers .
  • Bests Review is AM Bests monthly insurance magazine, covering emerging insurance issues and trends and evaluating their impact on the marketplace.
  • Full access to the complete content of Bests Review is available here .

COVID-19-Induced Stillbirths Caused by Placental Destruction and Failure

Retrieved on: 
Thursday, February 10, 2022

In November, the U.S. Centers for Disease Control and Prevention reported that pregnant women with COVID-19 have increased risk for stillbirths.

Key Points: 
  • In November, the U.S. Centers for Disease Control and Prevention reported that pregnant women with COVID-19 have increased risk for stillbirths.
  • Our study identified placental insufficiency as the root cause for stillbirths in women with COVID-19 during pregnancy.
  • The viral-induced lesions in the placenta obstructed maternal and fetal blood flow and oxygen exchange and caused irreparable damage and necrosis of placental tissues.
  • Worldwide, it is estimated there are up to six million stillbirths a year, and most result from placental failure.

HEVĒ, Part of [INVNT GROUP], to Launch “ORIGINS” A Division Dedicated to Accelerating Growth for Start-Ups

Retrieved on: 
Wednesday, February 2, 2022

Since its launch 3 years ago, HEV has experienced rapid growth across industry sectors taking BrandStories to new heights.

Key Points: 
  • Since its launch 3 years ago, HEV has experienced rapid growth across industry sectors taking BrandStories to new heights.
  • Today, they announce the launch of a new agency focus ORIGINS by HEV dedicated to innovative start-ups in the health, wellness, and fitness space.
  • In response, HEV developed a dedicated solution for early-stage companies to enter the market in a meaningful way.
  • ORIGINS by HEV will be headed up by seasoned health and wellness expert, Bill Stump as Senior Vice President of Growth Strategies.